GPT and steatosis: They showed that supplementation with omega-3 PUFAs affected the improvements in 6 of 13 metabolic outcomes (TC, LDL, HDL, TG, HOMA-IR, and BMI) and ALT and GGT (but not in AST), in the liver content (MRI), and in the steatosis score (USG).